12:00 AM
 | 
Feb 25, 2013
 |  BC Week In Review  |  Company News  |  Deals

Amgen, Selexis deal

The companies expanded a 2004 R&D license to grant Amgen non-exclusive rights to...

Read the full 44 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >